المؤلفون: Ganju V., Boolell V., Alamgeer M., Watkins D.N.

مصطلحات الفهرس: non small cell lung cancer/dt [Drug Therapy], oncogene, oncogene K ras, protein targeting, review, squamous cell lung carcinoma/dt [Drug Therapy], afatinib/dt [Drug Therapy], aflibercept/dt [Drug Therapy], anaplastic lymphoma kinase/ec [Endogenous Compound], anaplastic lymphoma kinase inhibitor/dt [Drug Therapy], anaplastic lymphoma kinase inhibitor/pd [Pharmacology], antineoplastic agent/dt [Drug Therapy], B Raf kinase/ec [Endogenous Compound], bevacizumab/cb [Drug Combination], bevacizumab/dt [Drug Therapy], carboplatin/cb [Drug Combination], carboplatin/cm [Drug Comparison], carboplatin/dt [Drug Therapy], cisplatin/cb [Drug Combination], cisplatin/cm [Drug Comparison], cisplatin/dt [Drug Therapy], cytotoxic T lymphocyte antigen 4/ec [Endogenous Compound], dacomitinib/dt [Drug Therapy], dacomitinib/pd [Pharmacology], docetaxel/cb [Drug Combination], docetaxel/dt [Drug Therapy], epidermal growth factor receptor/ec [Endogenous Compound], erlotinib/dt [Drug Therapy], fibroblast growth factor receptor 1/ec [Endogenous Compound], gefitinib/dt [Drug Therapy], gemcitabine/cb [Drug Combination], gemcitabine/dt [Drug Therapy], navelbine/cb [Drug Combination], navelbine/dt [Drug Therapy], nintedanib/cb [Drug Combination], nintedanib/dt [Drug Therapy], paclitaxel/cb [Drug Combination], paclitaxel/cm [Drug Comparison], paclitaxel/dt [Drug Therapy], pemetrexed/cb [Drug Combination], pemetrexed/dt [Drug Therapy], platinum complex/dt [Drug Therapy], programmed death 1 receptor/ec [Endogenous Compound], protein tyrosine kinase/ec [Endogenous Compound], protein tyrosine kinase inhibitor/dt [Drug Therapy], protein tyrosine kinase inhibitor/pd [Pharmacology], somatomedin C receptor/ec [Endogenous Compound], tumor marker/ec [Endogenous Compound], unclassified drug, unindexed drug, vasculotropin/ec [Endogenous Compound], BRAF gene, mesenchymal epithelial transition, RET gene, ROS1 gene, protein DDR/ec [Endogenous Compound], nonhuman, advanced cancer/dt [Drug Therapy], cancer combination chemotherapy, cancer immunotherapy, cancer stem cell, cancer survival, cancer therapy, cell function, clinical trial (topic), comparative effectiveness, drug efficacy, drug protein binding, drug safety, elderly care, gene mutation, human, lung adenocarcinoma/dt [Drug Therapy], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/40909
Cancers
LibKey Link